Development of a metallurgical Canadian platform for the processing of added-value materials and semi-finished products for the global medical industry

本提案的目的是为全球医疗业开发一个用于加工附加值材料和半成品的加拿大冶金平台。重点介绍了用于制造半成品医疗产品的？钛合金。心血管应用主要是有针对性的。用于医疗产品和保健品的钛合金因其重量轻、高机械性能和无可争辩的生物兼容性而成为一种有价值的替代品。将获得力学性能的初步模式，并通过实验室经验和模拟连续优化。此外，心血管设备需要特殊的表面修饰和高质量的生产标准，因此将开发一种综合方法。将讨论半成品的设计、优化以及测试。这需要大量的高技术、高人员和高时间。在这个项目中，拉瓦尔大学的生物材料和生物工程实验室和魁北克医学中心将组成一支出色的熟练团队，这两个实验室的专业知识互补。第一个项目将带来医疗器械生物材料领域15年以上的学术和工业专业知识，而第二个项目将为该项目注入生产作为基础材料的ç-钛合金和半成品所需的彻底的科学和技术环境，并采用真正面向技术转让的方法。四家高度互补和值得信赖的公司将提供其核心业务的直接专业知识，以及与实际生产过程相关的材料、技术、服务和知识反馈。这种深层次的交流将有利于高素质人员的教育，使他们接触到高科技环境和开发知识产权的机会，并成为该项目(已经设想的)下一步发展的一部分。如果该项目成功，加拿大有可能成为下一代心血管设备新的先进材料和半成品的世界罕见供应商之一。

The present proposal is aimed to develop a metallurgical Canadian platform for the processing of added-value materials and semi-finished products for the Global medical industry. The focus is addressed over ß-Ti alloys to fabricate semi-finished medical products. Cardiovascular applications are mainly targeted. Titanium alloys for medical products and healthcare goods represents a valuable alternative for their low weight, high mechanical properties and uncontested biocompatibility. A preliminary pattern of the mechanical properties will be obtained and successively optimised by laboratory experiences and simulations. In addition, cardiovascular devices need specific surface modification and high quality production standards, so that an integrated approach will be developed. The design, the optimization, as well as testing of semi-finished products will be addressed. This requires plenty of high technology, personnel and time. In this project, an exceptional and skilled team will be constituted by the complementary expertise of Laboratory for Biomaterials and Bioengineering at Université Laval and Centre de Métallurgie du Québec, in Trois-Rivières. The first will bring more than 15 years of academic and industrial expertise in the field of biomaterials for medical devices while the second will inject in this project the thorough scientific and technological environment required for the production of ß-Ti alloys, as base material, and semi-finished products, with a genuine technological-transfer-oriented approach. Four highly complementary and trustable companies will provide direct expertise from their core business, but also materials, technology, services and knowledge feedbacks related to factual production processes. This deep level of exchange will benefit toward the education of high quality personnel, by exposing them to a high technology environment and the chance of developing intellectual properties and be part of the (already envisaged) next development of this project. This project, if successful, presents the potential for Canada to become one of the rare world-supplier for new advanced materials and semi-finished products for the next generation of cardiovascular devices.